Abstract
Background COVID-19 vaccination rates among children have stalled, while new coronavirus strains continue to emerge. To improve child vaccination rates, policymakers must better understand parental preferences and reasons for COVID-19 vaccination among their children.
Methods and Findings Cross-sectional surveys were administered online to 30,174 US parents with at least one child of COVID-19 vaccine eligible age (5-17 years) between January 1 and May 9, 2022. Participants self-reported willingness to vaccinate their child and reasons for hesitancy, and answered additional questions about demographics, pandemic related behavior, and vaccination status. Willingness to vaccinate a child for COVID-19 was strongly associated with parental vaccination status (multivariate odds ratio 97.9, 95% confidence interval 86.9-111.0). The majority of fully vaccinated (86%) and unvaccinated (84%) parents reported concordant vaccination preferences for their eligible child. Age and education had differing relationships by vaccination status, with higher age and education positively associated with willingness among vaccinated parents. Among all parents hesitant to vaccinate their children, the two most frequently reported reasons were possible side effects (47%) and that vaccines are too new (44%). Among hesitant parents, parental vaccination status was inversely associated with reported lack of trust in government (p<.001) and scientists (p<.001). Cluster analysis identified three groups of hesitant parents based on their reasons for hesitance to vaccinate, with distinct concerns that may be obscured when analyzed in aggregate.
Conclusion Factors associated with willingness to vaccinate children and reasons for hesitancy may inform targeted approaches to increase vaccination.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Dr. Astley acknowledges funding from NIH/NIDDK: K23 DK120899. Ben Rader, Autumn Gertz, and Dr. Brownstein acknowledge funding from the Centers for Disease Control and Prevention. The funding organizations had no role in the design and conduct of the study collection, management, analysis, and interpretation of the data preparation, review, or approval of the manuscript and decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Boston Children’s Hospital Institutional Review Board and received a waiver of informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Contact: neil_sehgal{at}g.harvard.edu
Data Availability
Data used for all analyses, tables, and figures available here: https://github.com/sehgal-neil/parental-vaccine-hesitancy
